Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Duke Medicine Circle
Durham, NC 27710
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2022 - 2025
University of MichiganResidency, Internal Medicine, 2019 - 2022
Weill Cornell MedicineClass of 2019, MD
Princeton UniversityAB, Molecular Biology, magna cum laude, 2015
Certifications & Licensure
NC State Medical License 2022 - 2025
MI State Medical License 2019 - 2021- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 38 citationsA New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Natalie J. Miller, Lucia Carril-Ajuria
European Urology Oncology. 2021-06-01 - 7 citationsAssociation of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma.Rafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos, Scott Dawsey
Clinical Genitourinary Cancer. 2022-12-01 - 11 citationsAssociation Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos, Scott Dawsey
Clinical Genitourinary Cancer. 2022-10-01
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
